Noradrenaline Bitartrate Injection

Product Description

Packing : 2 Ml Ampoule, 4 Ml Ampoule.

Available Strength : 1 mg/ml, 2 Mg/Ml

Noradrenaline Bitartrate Injection is a high-quality sterile vasopressor formulation manufactured by Montage Laboratories Pvt. Ltd. Each ampoule contains Noradrenaline Bitartrate, a potent sympathomimetic agent that primarily stimulates alpha-adrenergic receptors, resulting in vasoconstriction and an increase in blood pressure.

It is commonly used in the management of acute hypotension, septic shock, cardiogenic shock, and other critical care situations requiring rapid restoration of vascular tone and blood pressure. Manufactured under stringent cGMP and ISO-certified quality standards, Noradrenaline Bitartrate Injection ensures safety, stability, and consistent therapeutic performance.

Montage Laboratories Private Limited

Country/Region:

India
On CPHI since:

2023
Certificates:

3
Employees:

250 - 499

Company types

Manufacturer/Innovator

Pharmaceutical company

Primary activities

Animal Health

Contract Manufacturer

Finished Formulation products Distributor/Buyer

Marketing Services Provider

Nutraceuticals

Pharmaceutical Company (generic finished products)

Compare Add to favorites Added to favorites

Specifications

Details

Product Description : Noradrenaline Bitartrate Injection is a sterile solution containing noradrenaline bitartrate, a sympathomimetic agent, for intravenous administration. It acts as a potent vasoconstrictor and cardiac stimulant, primarily used to increase blood pressure in cases of severe hypotension and shock.

Indications and Usage : Noradrenaline Bitartrate Injection is indicated for the treatment of acute hypotension and shock, including septic shock, cardiogenic shock, and hypotension during anesthesia. It is used to maintain blood pressure and organ perfusion in critically ill patients.

Dosage and Administration : The dosage of Noradrenaline Bitartrate Injection varies depending on the patient's age, weight, and clinical condition. It is administered intravenously through a central venous line to minimize the risk of extravasation. The infusion rate is titrated to achieve the desired hemodynamic response, typically starting at 0.05 to 0.2 mcg/kg/minute.